Denmark's seaside town of Kalundborg is also known as "Novo Town." It's the core of pharmaceutical company Novo Nordisk's production empire. Wegovy, launched in 2021, made Novo Nordisk Europe's most valuable company. Since then, fierce competition has slowed Wegovy sales and Novo Nordisk's share price has plunged by more than $400 billion. Denmark's senior correspondent Jacob Gronholt-Pedersen explores the impact of the company on a single town.

Sign up for the Reuters Econ World newsletter ⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠.

Listen to the Reuters Econ World podcast ⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠.

Listen to Reuters World News ⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠.

Visit the Thomson Reuters Privacy Statement for information on our privacy and data protection practices.

You may also visit megaphone.fm/adchoices to opt out of targeted advertising.